MATRIX EG (Matuzumab Treatment With ECX in Esophago-Gastric Cancer)

Mise à jour : Il y a 5 ans
Référence : NCT00215644

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to compare the effectiveness and safety of experimental treatment matuzumab and ECX chemotherapy, with ECX chemotherapy. Subjects invited to take part have metastatic cancer of the esophagus (gullet) or stomach.


Critère d'inclusion

  • Esophageal Cancer,Gastric Cancer

Liens